Real-time enrollment status for this metastatic her2-negative breast carcinoma clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 1:32 AM UTC
| NCT Number | NCT05770531 |
| Recruiting Status | Recruiting |
| Condition | Metastatic HER2-Negative Breast Carcinoma |
| Phase | PHASE2 |
| Target Enrollment | 160 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Vanderbilt-Ingram Cancer Center |
| Last Updated on CT.gov | June 24, 2026 (Jun 24, 2026) |
As of September 2, 2026: Clinical trial NCT05770531 is currently recruiting participants. This phase2 study for metastatic her2-negative breast carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Vanderbilt-Ingram Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05770531 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05770531 was last updated Jun 24, 2026 (June 24, 2026). HelloStudys verifies this status automatically.